Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Capital/Financing Update 2022

Nov 9, 2022

61176_rns_2022-11-09_ff4fc9f5-55a1-464e-afc5-cff1d17b14e6.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T: 91 80 2808 2808 F: 91 80 2852 3423 CIN : L24234KA1978PLC003417 www.biocon.com

November 9, 2022

To,The SecretaryBSE LimitedDepartment of Corporate ServicesPhiroze Jeejeebhoy Towers,Dalal Street,Mumbai – 400 001 To,The SecretaryNational Stock Exchange of India LimitedCorporate Communication DepartmentExchange Plaza, Bandra Kurla ComplexMumbai – 400 050
Scrip Code – 532523 Scrip Symbol - Biocon

Subject: Intimation pursuant to Regulation 29(1)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Dear Sir/Madam,

This is further to our letter dated October 20, 2022, intimating the date of the Board meeting scheduled to be held on Monday, November 14, 2022.

Please be informed that the Board at the aforesaid meeting shall also consider the issue of Redeemable, Non-Convertible Debentures and / or Commercial Paper on private placement basis, amongst other matters.

The above-mentioned information will also be available on website of the Company at www.biocon.com.

Request you to take the above intimation on record.

Thanking You,

For Biocon Limited

MAYAN Digitally signed by MAYANK K VERMA Date: 2022.11.09 VERMA 19:38:17 +05'30' _______________

Mayank Verma

Company Secretary and Compliance Officer